Media & Press Updates
Israel Biotech Fund
We are excited to step into 2022 together with #IBF
https://israelbiotechfund.com/
Proud to be part of exclusive portfolio of innovative #lifesciences companies.
This #funding accelerates the path towards clinical stage of our #first-in-class #biotherapy targeting #cancers with #p53 mutations.
We are on mission to bring #cure to cancer patients.
December 31, 2021
Virtual MedInvest Oncology Investor Conference
This week ExoProTher Medical presented at the virtual MedInvest Oncology Investor Conference. ExoProTher’s Chief Executive Officer, Lana Volokh, delivered the corporate overview. She described the Company’s unique scientific foundation and technology and provided an update on program status. ExoProTher aims to significantly impact the way cancer is treated. Link to the presentation recording: https://youtu.be/JxwwiSTyrwk .
December 11, 2021
PAT-ICRS workshop
In lab Investors event
Investors event in our R&D Lab at Colab square Yokneam, taking a glimpse into the digital microscope along with markers on milestones achieved.
July 9th, 2021
New R&D lab at Colab Square Facility, Yokneam
Beginning May 2021, ExoProTher is operating a new R&D lab situated at unique Colab Square facility in Yokneam Industrial park. ExoProTher is joining a line of exciting and promising biotech companies.
The combination of location, equipment and environment allow to boost R&D activities and attract top talent to the expanding team.
June 24, 2021
2021 Virtual World Stem Cell Summit
ExoProTher Medical - Co-founder & CEO Dr. Lana Volokh
at The Investor Forum - at the 2021 Virtual World Stem Cell Summit. (hosted by channelchek)
June 17th, 2021
SEV2021 Annual Meeting
ExoProTher's scientific abstract reporting our recent preclinical results at the Annual Meeting of International Society for Extracellular Vesicles.
May 18-21, 2021
Magische kugel against cancer
"Magic bullet against cancer"
Short Communication - Journal of Molecular Oncology Research (2021) Volume 5, Issue 2
March 10th, 2021
New media coverage - Globes article featuring ExoProTher
ExoProTher article in Israeli business daily the "Globes".
Hebrew article by Globes' biomed reporter, Gali Weinreb.
January 6th, 2021
Startup World Cup
ExoProTher is honored to be selected among top ten Israeli companies in the largest startup competition in the world - Startup World Cup.
Best regards,
Lana Volokh - CEO
January 5th, 2021
ExoProTher milestone achieved
I am pleased to share with our followers and investors the latest in vivo results.
Two weeks ago, a successful in vivo experiment on mouse model of colon cancer ended with impressive results. Life span of treated mice was significantly prolonged after single dose of Exo, while 25% of them remained tumor-free after the experiment completion. Additional in vivo studies using other cancer models are in progress.
Best regards,
Lana Volokh - CEO
November 12, 2020
New recruits & Additional facility
Exciting growth period for ExoProTher Medical: we opened a new laboratory facility and brought on board new talent.
The new laboratory started functioning in Shlomi, Israel. It will focus on optimizing production and characterization of EXO_ compounds.
With extended R&D team, we continue to broaden and deepen our research capabilities.
September 13, 2020
SoCal
Startup Day
Velocity on the rise not only in our labs.
Great boost coming from amazing crowd engagement in the SoCal startup event.
February 26, 2020
SoCal
Startup Day
We are excited to attend the SoCal Startup Day and present our development.
Come see our quick-fire presentation as part of the start-up competition and visit us at booth #22 to learn more about our unique approach.
February 26, 2020
@Tel-Aviv stock exchange
ExitValley and Eternity Capital investors event at the Tel-Aviv stock exchange.
February 5, 2020
Call for Action
ExoProTher VP Business Development update and call for action.
December 12, 2019
ExitValley's campaign
About a week into the campaign and the traction is high,
More than 100% of initial funding target.
December 9, 2019
ExitValley's Investors meeting
What a great event to be part of – first ExitValley’s Investors meeting!
Dr. Alex Tendler, co-founder and CTO of ExoProTher Medical, presented our unique concept and its outstanding potential to the very interested audience.
Excellent traction,
ExoProTher Medical launched the crowdfunding campaign using ExitValley platform.
It is super cool to see first investment after less than 12 hours. Amazing start.
December 2, 2019
TheMarker's OncoTalk
publication
Harness evolution to fight cancer
OncoTalk's brief - exposing ExoProTher innovative approach
September 2019